SkinPen Microneedling

In Stock Unavailable

Regular price £0

Item ATLAS Retailer

Star seller

Shop with confidence

Item ATLAS sellers went through all the hardle to open an online shop and start selling from their own online shop. It is not easy to start and run own online business.

Product Details

WHAT IS SKINPEN?

SkinPen by Bellus Medical is the first microneedling device cleared by the U.S. Food and Drug Administration, clinically proven to safely and effectively treat facial acne scars for ages 22 and up.

With as few as three non-invasive and affordable treatments spaced 30 days apart, you can improve your appearance for six months after your last treatment – and step out with confidence.

FEATURES AND BENEFITS

SkinPen creates controlled micro-injuries to stimulate the body’s natural wound-healing process, while minimizing cellular damage. The result is effective remodeling of scar tissue, while keeping the overall structure of the skin intact.

  • 90% Would Recommend SkinPen to Friends and Family
  • Unbeatable SafetyThe World’s First FDA-Cleared Microneedling Device
  • Works for All Skin Types
  • Hassle-Free
  • Get Back to Living With Little Downtime

HOW MICRONEEDLING WORKS

SkinPen by Bellus Medical is the first FDA-cleared microneedling device.

It causes controlled micro-injuries that stimulate your body’s natural wound healing process, while minimizing cellular damage. The result is effective remodeling of scar tissue, while keeping the overall structure of the skin intact.1

There are three phases to the wound-repair process:

  1. Phase I: Inflammation. Piercing the skin triggers your immune system to disinfect the wounds, remove debris, increase blood flow and begin to create new tissue.
  2. Phase II: Proliferation. The wound is rebuilt with new granulation cells, which are part of the extracellular matrix. Additionally, a new network of blood vessels develops.
  3. Phase III: Remodeling. The wound is replaced with new dermal tissues and blood vessels.

Best of all, SkinPen works. Ninety percent of subjects in the clinical trial would recommend the procedure to family and friends.